Responding to developments | Cutting through the noise | Promoting diverse voices | Shaping opinion | Making connections | Pointing to the evidence

Could machine learning mean the end of empirical prescribing?

7th July 2020

A technological revolution is poised to transform healthcare forever. Ed Moran, Consultant in Infectious Disease, explores how machine learning could soon be used to improve antibiotic selection...

BSAC meets WHO: Professor Hanan H. Balkhy answers questions on the GLASS Report 2020

30th June 2020

Following the publication of the WHO's latest Global Antimicrobial Resistance and Use Surveillance System (GLASS) report, we caught up with Professor Hanan H. Balkhy to find out how data from the report will be used to stop superbugs...

Immediate call for partner university and principal investigator for the further development of a UK Antimicrobial Registry (UKAR).

29th June 2020

BSAC is establishing a UK Drug Registry (UKAR) to provide prescribers and organisations the opportunity to capture real world usage of antimicrobial agents and identify where real clinical unmet needs lie. This will provide an invaluable resource for future research studies and also enable the sharing of best practice.

Superbugs & game theory: Rates of resistance will continue to increase unless we change the “payoff” for prescribers

23rd June 2020

An international research project based at the University of Leicester recently provided the first detailed mathematical proof that antibiotic over-prescribing is a social dilemma of ‘the tragedy of the commons type’. Andrew Colman outlines how this was achieved with the help of game theory.

BSAC delighted to publish in relaunched APUA newsletter

18th June 2020

BSAC is delighted to be part of the Alliance for the Prudent Use of Antibiotics, now part of the International Society for Antimicrobial Chemotherapy.

BSAC calls for Minister to tackle superbugs and pandemics in response to inquiry on COVID-19 impact

17th June 2020

BSAC has made three key recommendations in its response to the UK Parliament’s Health and Social Care Select Committee’s inquiry, “Delivering Core NHS and Care Services during the Pandemic and Beyond”

BSAC responds to UN consultation on panel to coordinate action against superbugs

16th June 2020

Following the Interagency Coordination Group’s (IACG) recommendation that the UN Secretary General should establish an Independent Panel on Evidence on Action Against Antimicrobial Resistance, an advisory group was established to develop draft Terms of Reference (ToR) for the Panel. Here is the British Society for Antimicrobial Chemotherapy’s (BSAC) response to that draft.

Poverty and drug resistance: the context needs to change, not the understanding of patients

16th June 2020

While stewardship programmes have some impact on antimicrobial resistance, hardship, particularly in low- and middle-income countries, means traditional awareness-raising campaigns are likely to fail. Is it time for a new approach, focused on community-building?

1 2 3 5
GP? Pharmacist? Researcher? Social Scientist? Whatever field you work in, if you’re committed to fighting infection then we want you to join us as a BSAC Member.
Become a member
I have read and agree to the Privacy Policy

Having trouble finding what you're after?

Top